Track A - Scaling Science: The Next Stage for St. Louis' HealthTech & Biotech Innovators

As St. Louis continues to emerge as a national leader in HealthTech and Biotech innovation, a new wave of startups is moving beyond early-stage success and into high-growth expansion. This panel will feature founders and executives from the region’s fastest-growing health and life sciences companies who have recently secured growth capital investment (some Series B & C), positioning them for rapid scaling, commercialization, and broader market impact. Panelists will discuss the evolving investment landscape, the strategic milestones that attract later-stage capital, and how they are leveraging funding to expand operations, accelerate clinical development, navigate regulatory pathways, and enter new markets. With growing support from venture capital, corporate partnerships, and a maturing ecosystem, St. Louis’ HealthTech and Biotech scaleups are proving that breakthrough science can translate into high-growth businesses that drive economic and healthcare transformation.